Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy

This publication has 8 references indexed in Scilit:

• Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance
  Published by Elsevier ,2002
• Leptin-Replacement Therapy for Lipodystrophy
  New England Journal of Medicine, 2002
• Clinical perspectives on HIV-associated lipodystrophy syndrome: an update
  AIDS, 2001
• The HIV Protease Inhibitor Indinavir Impairs Sterol Regulatory Element-Binding Protein-1 Intranuclear Localization, Inhibits Preadipocyte Differentiation, and Induces Insulin Resistance
  Diabetes, 2001
• Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy
  AIDS, 2000
• A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy
  AIDS, 1999
• Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus.
  Zeitschrift für Die Gesamte Experimentelle Medizin, 1999
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
  The Lancet, 1999